IRIS
BLONDEAUX, EVA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.786
Totale 1.786
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 1.786
Totale 1.786
Salva come PNG Salva come JPEG
Città #
Genova 1.026
Genoa 305
Rapallo 268
Vado Ligure 169
Bordighera 18
Totale 1.786
Salva come PNG Salva come JPEG
Nome #
Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study 139
Management of young women with early breast cancer 118
News on the medical treatment of young women with early-stage HER2-negative breast cancer 114
Role of fulvestrant in the treatment of postmenopausal metastatic breast cancer patients 114
The PREgnancy and FERtility (PREFER) study: An Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patients 111
Treatment with aromatase inhibitors and markers of cardiovascular disease 105
Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis 95
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review 93
Improving Adjuvant Endocrine Treatment Tailoring in Premenopausal Women With Hormone Receptor-Positive Breast Cancer 93
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study 92
Role of dose-dense chemotherapy in high-risk early breast cancer 89
Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study 75
PICC-PORT totally implantable vascular access device in breast cancer patients undergoing chemotherapy 73
Current State of the Art in the Adjuvant Systemic Treatment of Premenopausal Patients With Early Breast Cancer 73
Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial 68
Tumor-to-nipple Distance Should Not Preclude Nipple-sparing Mastectomy in Breast Cancer Patients. Personal Experience and Literature Review 65
Moving trastuzumab emtansine (T-DM1) to the early setting of breast cancer treatment 57
Moving trastuzumab emtansine (T-DM1) to the early setting of breast cancer treatment 41
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial 35
The Role of Cyclin-Dependent Kinases (CDK) 4/6 in the Ovarian Tissue and the Possible Effects of Their Exogenous Inhibition 33
null 27
Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study 23
Experience with a nurse-driven genetic counseling pathway of Italian women with uninformative BRCA test result 23
Safety of pregnancy after breast cancer in young women with hormone receptor-positive disease: a systematic review and meta-analysis 22
Prognostic and clinical impact of the endocrine resistance/sensitivity classification according to international consensus guidelines for advanced breast cancer: an individual patient-level analysis from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) studies 19
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial 16
Patterns of care at the end of life: a retrospective study of Italian patients with advanced breast cancer 15
Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer-results from an international, multicenter analysis coordinated by the AGMT Study Group 13
Intermediate clinical endpoints in early-stage breast cancer: an analysis of individual patient data from the Gruppo Italiano Mammella and Mammella Intergruppo trials 13
Prognostic value of HER2-low status in breast cancer: a systematic review and meta-analysis 8
Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial 8
Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study 8
Enhanced patient journey associated with improved overall survival in colon cancer patients: A study by the Ligurian Oncology Network 2
The journey of patients affected by metastatic hormone receptor-positive/HER2-negative breast cancer from CDK 4/6 inhibitors to second-line treatment: A real-world analysis of 701 patients enrolled in the GIM14/BIOMETA study 1
Totale 1.881
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.058
article - articoli 8.058
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.116
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020431 0 0 0 0 49 73 68 55 59 70 42 15
2020/2021251 20 12 41 27 12 27 10 24 22 25 16 15
2021/2022235 4 9 5 38 15 24 12 44 25 23 8 28
2022/2023314 25 30 3 35 61 47 8 19 43 4 37 2
2023/2024269 6 20 4 38 16 30 21 14 9 25 21 65
2024/2025201 39 52 24 38 48 0 0 0 0 0 0 0
Totale 1.881